Cargando…

The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis

BACKGROUND: Production of the chemokine CCL2 by cells of the neurovascular unit (NVU) drives critical aspects of neuroinflammation. Suppression of CCL2 therefore holds promise in treating neuroinflammatory disease. Accordingly, we sought to determine if the compound bindarit, which inhibits CCL2 syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Shujun, Shrestha, Bandana, Paul, Debayon, Keating, Carolyn, Cone, Robert, Guglielmotti, Angelo, Pachter, Joel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488971/ https://www.ncbi.nlm.nih.gov/pubmed/22788993 http://dx.doi.org/10.1186/1742-2094-9-171

Ejemplares similares

Active induction of experimental autoimmune encephalomyelitis by MOG(35-55) peptide immunization is associated with differential responses in separate compartments of the choroid plexus
por: Murugesan, Nivetha, et al.
Publicado: (2012)

Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation
por: Shrestha, Bandana, et al.
Publicado: (2014)

The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
por: Grassia, Gianluca, et al.
Publicado: (2009)

Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching
por: Maddaluno, Marcella, et al.
Publicado: (2012)

Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties
por: Shen, Zongshan, et al.
Publicado: (2020)

Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation
por: Paul, Debayon, et al.
Publicado: (2014)

Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway
por: Yuan, Shi‐guo, et al.
Publicado: (2022)

Appearance of claudin-5(+) leukocyte subtypes in the blood and CNS during progression of EAE
por: Krajewski, Dylan, et al.
Publicado: (2021)

Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment
por: Wolf, Stefan, et al.
Publicado: (2017)

Human ES-derived MSCs correct TNF-α-mediated alterations in a blood–brain barrier model
por: Ge, Shujun, et al.
Publicado: (2019)

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes
por: Li, Rui, et al.
Publicado: (2014)

Prevention of Obesity Related Diseases through Laminarin-induced targeted delivery of Bindarit
por: Xu, Chunmei, et al.
Publicado: (2020)

Appearance of claudin-5(+) leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles
por: Paul, Debayon, et al.
Publicado: (2016)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022)

Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats
por: Milosevic, Ana, et al.
Publicado: (2021)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control
por: Bolton, C.
Publicado: (1997)

RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells
por: Tang, Shi, et al.
Publicado: (2022)

Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus
por: Xie, Changping, et al.
Publicado: (2006)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Kinin B(2 )receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice
por: Dos Santos, Adriana C, et al.
Publicado: (2008)

Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers
por: Ramirez, Servio H., et al.
Publicado: (2018)

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
por: Sharp, Anthony J, et al.
Publicado: (2008)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid
por: Irving, Amy A., et al.
Publicado: (2017)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells
por: Klose, Juliane, et al.
Publicado: (2013)

The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells
por: Oddi, Sergio, et al.
Publicado: (2019)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium
por: Estevao, Carolina, et al.
Publicado: (2021)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Molecular effects of curcumin on the experimental autoimmune encephalomyelitis
por: Mavaddatiyan, Laleh, et al.
Publicado: (2021)

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
por: Carrillo-Salinas, Francisco J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ln2ktg5faun8t6slt43b2fg0t0